Blocking TIGIT/CD155 signalling reverses CD8+ T cell exhaustion and enhances the antitumor activity in cervical cancer
2022 · Journal of Translational Medicine · 73 citations
https://doi.org/10.1186/s12967-022-03480-x
A
Aihong Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
51
Papers
984
Citations
17
h-index
24
i10-index
Aihong Wang is an academic researcher from Albert Einstein College of Medicine. The author has contributed to research in topics: MicroRNA in disease regulation & Immune Cell Function and Interaction & Cancer-related molecular mechanisms research. The author has an h-index of 17, co-authored 44 publications.
ORCID: 0000-0003-1110-9928Papers by this author
worksCervical cancer-derived exosomal miR-663b promotes angiogenesis by inhibiting vinculin expression in vascular endothelial cells
2021 · Cancer Cell International · 33 citations
https://doi.org/10.1186/s12935-021-02379-9
A Small Molecule Inhibitor, OGP46, Is Effective against Imatinib-Resistant BCR-ABL Mutations via the BCR-ABL/JAK-STAT Pathway
2020 · Molecular Therapy — Oncolytics · 16 citations
https://doi.org/10.1016/j.omto.2020.06.008
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat